SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 492 filers reported holding SEAGEN INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $236,547 | +42.3% | 1,115 | +29.1% | 0.02% | +50.0% |
| Q2 2023 | $166,285 | -98.3% | 864 | -98.2% | 0.01% | -91.0% |
| Q1 2023 | $9,869,198 | -8.7% | 48,744 | -42.1% | 0.13% | -16.9% |
| Q4 2022 | $10,813,989 | -99.9% | 84,149 | +15.2% | 0.16% | +5.3% |
| Q3 2022 | $9,994,201,000 | -31.9% | 73,041 | -12.0% | 0.15% | -20.4% |
| Q2 2022 | $14,679,474,000 | +5.6% | 82,963 | -14.0% | 0.19% | +19.4% |
| Q1 2022 | $13,903,706,000 | -8.9% | 96,520 | -2.2% | 0.16% | +1.3% |
| Q4 2021 | $15,262,885,000 | -16.8% | 98,725 | -8.6% | 0.16% | -19.4% |
| Q3 2021 | $18,346,381,000 | +732.5% | 108,047 | +674.1% | 0.20% | +790.9% |
| Q2 2021 | $2,203,689,000 | +13.7% | 13,958 | 0.0% | 0.02% | +4.8% |
| Q1 2021 | $1,938,208,000 | +33.3% | 13,958 | +68.1% | 0.02% | +23.5% |
| Q4 2020 | $1,454,363,000 | – | 8,304 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |